Abstract
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive mediastinal staging tool for lung cancer but also a diagnostic tool for mediastinal lesions near the airway. This review focuses primarily on the technique of linear probe EBUS-TBNA itself, training and financial issues, indications and performance, and pros and cons compared to other mediastinal sampling techniques. As such, it is relevant to centres considering to establish an EBUS-TBNA service. EBUS-TBNA is the most commonly used for staging non-small cell lung cancer (NSCLC), particularly bulky mediastinal lymphadenopathy and enlarged N2 or N3 disease on CT, but is also used for the diagnosis of unexplained mediastinal lymphadenopathy of other causes. For staging when radical treatment is contemplated, many centres still perform mediastinoscopy and this should be done in order to corroborate negative EBUS-TBNA results in this setting or when the pre-test clinical probability of lung cancer is high. EBUS-TBNA may be used in the future for staging, when the mediastinal nodes are normal according to radiological staging and also in re-staging. EBUS-TBNA can be learned with appropriate training and mentorship; it offers numerous advantages over mediastinoscopy and can reduce costs by avoiding mediastinoscopy (and the required peri-operative support) in many cases.
Keywords: Lung cancer, diagnosis, staging, endobronchial ultrasound, transbronchial needle aspiration, mediastinoscopy
Current Respiratory Medicine Reviews
Title: Applications of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Pulmonary Disease
Volume: 6 Issue: 2
Author(s): Andrew R.L. Medford
Affiliation:
Keywords: Lung cancer, diagnosis, staging, endobronchial ultrasound, transbronchial needle aspiration, mediastinoscopy
Abstract: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive mediastinal staging tool for lung cancer but also a diagnostic tool for mediastinal lesions near the airway. This review focuses primarily on the technique of linear probe EBUS-TBNA itself, training and financial issues, indications and performance, and pros and cons compared to other mediastinal sampling techniques. As such, it is relevant to centres considering to establish an EBUS-TBNA service. EBUS-TBNA is the most commonly used for staging non-small cell lung cancer (NSCLC), particularly bulky mediastinal lymphadenopathy and enlarged N2 or N3 disease on CT, but is also used for the diagnosis of unexplained mediastinal lymphadenopathy of other causes. For staging when radical treatment is contemplated, many centres still perform mediastinoscopy and this should be done in order to corroborate negative EBUS-TBNA results in this setting or when the pre-test clinical probability of lung cancer is high. EBUS-TBNA may be used in the future for staging, when the mediastinal nodes are normal according to radiological staging and also in re-staging. EBUS-TBNA can be learned with appropriate training and mentorship; it offers numerous advantages over mediastinoscopy and can reduce costs by avoiding mediastinoscopy (and the required peri-operative support) in many cases.
Export Options
About this article
Cite this article as:
R.L. Medford Andrew, Applications of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Pulmonary Disease, Current Respiratory Medicine Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339810791171241
DOI https://dx.doi.org/10.2174/157339810791171241 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies “Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development
Current Medicinal Chemistry N-Hydroxyguanidines as Substrates of Nitric Oxide Synthases
Current Topics in Medicinal Chemistry Future Prospect of RNA Interference for Cancer Therapies
Current Drug Targets ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry Metabolic Response Assessment in Non-Small Cell Lung Cancer Patients after Platinum-Based Therapy: A Preliminary Analysis
Current Medical Imaging A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
Current Cancer Drug Targets KRAB-Zinc Finger Proteins: A Repressor Family Displaying Multiple Biological Functions
Current Genomics Aspartic Proteases in Drug Discovery
Current Pharmaceutical Design Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis
Current Gene Therapy Concise Synthesis of Benzoindolizidine Derivatives and Bioactivity Evaluation
Letters in Organic Chemistry Pharmacological Intervention at CCR1 and CCR5 as an Approach for Cancer: Help or Hindrance
Current Topics in Medicinal Chemistry Drugs, Environmental Factors, Loci and Genes Involved in Nonsyndromic Orofacial Cleft
Current Pharmacogenomics Flavonoids in Atherosclerosis: An Overview of Their Mechanisms of Action
Current Medicinal Chemistry Aminopeptidases of Malaria Parasites: New Targets for Chemotherapy
Infectious Disorders - Drug Targets Exploring the Role of Phytochemicals as Potent Natural Photosensitizers in Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Inflammation and Chronic Oxidative Stress in Radiation-Induced Late Normal Tissue Injury: Therapeutic Implications
Current Medicinal Chemistry Transforming Growth Factor-Beta and the Kidney: What We Know and What We Can Do?
Current Enzyme Inhibition Between Bench and Bed Side: PI3K Inhibitors
Current Molecular Pharmacology The Role of ABC Transporters in Protecting Cells from Bilirubin Toxicity
Current Pharmaceutical Design